Current guidelines for high-density lipoprotein cholesterol in therapy and future directions

Many studies have suggested that a significant risk factor for atherosclerotic cardiovascular disease (ASCVD) is low high-density lipoprotein cholesterol (HDL-C). Therefore, increasing HDL-C with therapeutic agents has been considered an attractive strategy. In the prestatin era, fibrates and niacin...

Descripción completa

Detalles Bibliográficos
Autores principales: Subedi, Bishnu H, Joshi, Parag H, Jones, Steven R, Martin, Seth S, Blaha, Michael J, Michos, Erin D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986285/
https://www.ncbi.nlm.nih.gov/pubmed/24748800
http://dx.doi.org/10.2147/VHRM.S45648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986285/
https://www.ncbi.nlm.nih.gov/pubmed/24748800
http://dx.doi.org/10.2147/VHRM.S45648

Ejemplares similares